Interpretable machine learning model for early prediction of deep vein thrombosis in elderly ICU patients: multicenter development and external validation
Aug 2026· BMC Medical Informatics and Decision Making· 0 citations
TL;DR
The developed and externally validated an interpretable machine learning model for early DVT prediction in elderly ICU patients may support risk stratification and clinical decision-making in critical care settings.
Abstract
Deep vein thrombosis (DVT) is a frequent complication in elderly intensive care unit (ICU) patients, while reliable prediction tools for this population remain limited. This study aimed to develop and externally validate an interpretable machine learning model for early prediction of DVT in critically ill elderly patients.
In this multicenter retrospective study, ICU patients aged ≥ 75 years from two tertiary medical centers in China were enrolled. Patients with pre-existing DVT were excluded. A development cohort (Suzhou,
n
= 1,717) and an external validation cohort (Xi’an,
n
= 533) were established. Clinical variables collected within 24 h after ICU admission were used to predict incident DVT during ICU stay. Least absolute shrinkage and selection operator regression was applied for feature selection, and four machine learning models were developed and compared. Model discrimination, calibration, and interpretability were evaluated using area under the curve (AUC), calibration analysis, and SHapley Additive exPlanations (SHAP).
DVT occurred in 15.2% and 21.0% of patients in the development and external validation cohorts, respectively. Among the evaluated models, XGBoost achieved the best performance, with AUCs of 0.843 in internal validation and 0.811 in external validation. Calibration analysis demonstrated good agreement between predicted and observed risks. Key predictors included D-dimer, C-reactive protein, platelet-to-lymphocyte ratio, procalcitonin, mechanical ventilation, and mechanical thromboprophylaxis. SHAP analysis quantified the contribution of individual predictors.
We developed and externally validated an interpretable machine learning model for early DVT prediction in elderly ICU patients. The model may support risk stratification and clinical decision-making in critical care settings.
Machine learning models demonstrated favorable performance for predicting in-hospital DVT after AIS, and SVM showed the most favorable overall performance, whereas XGBoost prioritized sensitivity.
Tie-Shi Zhu, Run-Zhui Lin, Le Zhao et al.· Frontiers in Neurology· 0 citations
BACKGROUND
Early mortality risk stratification remains challenging in intensive care unit (ICU) patients with acute upper gastrointestinal bleeding (AUGIB). We developed a parsimonious, interpretable ensemble model and evaluated its performance across independent ICU cohorts.
METHODS
MIMIC-IV was used for model devel...
Jian-Shan Shi, Yan-Fen Li, Wen-Xuan Li et al.· International Journal of Med...· 0 citations
Logistic Regression showed potential as an interpretable early ICU risk-stratification tool and externally validated machine learning models for in-hospital mortality prediction in patients with diabetes and ARDS.
Ya-Lin Dong, Meng-Xue Hou, Qian-Qian Wang et al.· Shock· 0 citations
Although the model shows potential for identifying high-risk individuals at the 24-hour prediction landmark, further prospective validation and clinical impact assessment are required before routine clinical implementation.
Zhang-Cong Lu, Ling-Han Hu, Peng-Fei Shui et al.· British journal of hospital...· 0 citations
The ML model developed in this study demonstrated superior accuracy, robustness, and generalizability in predicting early mortality in patients with SIC, and the findings provide valuable insights for prognostic assessment and the individualized management of patients with SIC.
Jia-Xuan Sun, Jing-Yuan Wang, Yu-Xin Dong et al.· JMIR Medical Informatics· 0 citations
The XGBoost model, integrating dynamic biomarkers and hematology-specific factors, provides superior personalized risk stratification for PICC-RT and enables the identification of high-risk patients who may benefit from enhanced surveillance or targeted thromboprophylaxis while safely identifying low-risk individuals.
Jian-Hong Su, Jun-Lin Hu, Wen-Tian Wang et al.· Supportive Care in Cancer· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.